title: Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery.
abstract: We have characterized the relationships between the design of cationic liposomes as a gene transfer vehicle, their resulting biodistribution and processing in animals, and the level and sites of gene expression they produce. By redesigning conventional cationic liposomes, incorporating cholesterol (chol) as the neutral lipid and preparing them as multilamellar vesicles (MLV), we increased the efficiency of cationic liposome:DNA complex (CLDC)-mediated gene delivery. Expression of the luciferase gene increased up to 1,740-fold and of the human granulocyte-colony stimulating factor (hG-CSF) gene up to 569-fold due to prolonged circulation time of injected CLDC, and increased uptake and retention in tissues. The level of gene expression per microgram of DNA taken up per tissue was 1,000-fold higher in lung than in liver, indicating that in addition to issues of delivery and retention of injected DNA, tissue-specific host factors also play a central role in determining the efficiency of expression. Vascular endothelial cells, monocytes, and macrophages are the cell types most commonly transfected by intravenous injection of CLDC.
authors.affiliation: California Pacific Medical Research Institute, San Francisco 94115, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Liu
authors.forename: L C
authors.initials: LC
authors.lastname: Mounkes
authors.forename: H D
authors.initials: HD
authors.lastname: Liggitt
authors.forename: C S
authors.initials: CS
authors.lastname: Brown
authors.forename: I
authors.initials: I
authors.lastname: Solodin
authors.forename: T D
authors.initials: TD
authors.lastname: Heath
authors.forename: R J
authors.initials: RJ
authors.lastname: Debs
mesh_terms: D000818:Animals; D002460:Cell Line; D002784:Cholesterol; D004247:DNA / Q000008:administration & dosage* / Q000378:metabolism; D004337:Drug Carriers; D015195:Drug Design; D017930:Genes, Reporter; D016179:Granulocyte Colony-Stimulating Factor / Q000096:biosynthesis* / Q000235:genetics; D006801:Humans; D007700:Kinetics; D008081:Liposomes; D008099:Liver / Q000378:metabolism; D008156:Luciferases / Q000096:biosynthesis; D008168:Lung / Q000378:metabolism; D008546:Melanoma, Experimental; D051379:Mice; D011994:Recombinant Proteins / Q000096:biosynthesis; D014162:Transfection / Q000379:methods*; D001616:beta-Galactosidase / Q000096:biosynthesis*
chemical_list: D004337:Drug Carriers; D008081:Liposomes; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D004247:DNA; D002784:Cholesterol; D008156:Luciferases; D001616:beta-Galactosidase